Cardio Diagnostics Holdings, Inc. financial data

Symbol
CDIO, CDIOW on Nasdaq
Location
Chicago, IL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 13 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1677% % 108%
Debt-to-equity 8.3% % -60%
Return On Equity -72% % 59%
Return On Assets -66% % 54%
Operating Margin -43737% % -82%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,959,469 shares -94%
Common Stock, Shares, Outstanding 1,826,051 shares 19%
Entity Public Float $5,800,000 USD -46%
Common Stock, Value, Issued $18 USD 20%
Weighted Average Number of Shares Outstanding, Basic 1,751,417 shares 95%
Weighted Average Number of Shares Outstanding, Diluted 1,751,417 shares 95%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $14,825 USD -58%
Research and Development Expense $641,212 USD 181%
Selling and Marketing Expense $1,239,387 USD 764%
General and Administrative Expense $4,339,195 USD -54%
Operating Income (Loss) $6,484,078 USD 22%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $6,498,167 USD 22%
Net Income (Loss) Attributable to Parent $6,498,167 USD 22%
Earnings Per Share, Basic -3.71 USD/shares 60%
Earnings Per Share, Diluted -3.71 USD/shares 60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $0 USD
Accounts Receivable, after Allowance for Credit Loss, Current $8,126 USD -56%
Assets, Current $5,920,703 USD -33%
Property, Plant and Equipment, Net $700,115 USD 4%
Operating Lease, Right-of-Use Asset $259,565 USD -40%
Assets $7,766,415 USD -27%
Liabilities, Current $604,839 USD -4.3%
Operating Lease, Liability, Noncurrent $188,222 USD -56%
Liabilities $793,061 USD -25%
Retained Earnings (Accumulated Deficit) $29,250,000 USD -29%
Stockholders' Equity Attributable to Parent $6,973,354 USD -27%
Liabilities and Equity $7,766,415 USD -27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,400,101 USD -14%
Net Cash Provided by (Used in) Financing Activities $3,308,748 USD 109%
Net Cash Provided by (Used in) Investing Activities $47,415 USD 32%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 1,766,607 shares -94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,110,630 USD -35%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,691 USD -19%
Deferred Tax Assets, Valuation Allowance $6,765,713 USD 21%
Deferred Tax Assets, Gross $6,765,713 USD 21%
Operating Lease, Liability $605,089 USD -27%
Depreciation $160,063 USD 41%
Payments to Acquire Property, Plant, and Equipment $5,787 USD -71%
Lessee, Operating Lease, Liability, to be Paid $445,767 USD 0%
Operating Lease, Liability, Current $237,607 USD 0.14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $250,152 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $65,610 USD 1.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $36,463 USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three $102,060 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $6,681,394 USD 20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $93,555 USD 0%
Operating Lease, Payments $64,827 USD 1.2%
Additional Paid in Capital $36,223,336 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $5,333 USD -67%
Interest Expense $14,801 USD -21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%